Epidemic Process of Haemophilus influenzae Infection in WHO Regions
- 10 March 2025
- journal article
- Published by LLC Numicom in Epidemiology and Vaccinal Prevention
- Vol. 24 (1)
Abstract
Relevance. Although the incidence of Hib infection has decreased in the last three decades, it is still significant. Even with appropriate treatment, the case-fatality rate can be as high as 5%. Up to 40% of children with infection may suffer lifelong complications. Although Hib infection is classified as vaccine-preventable, WHO and CDC do not post annual incidence information on their resources, unlike other vaccine-preventable infections. Therefore, an assessment of the global epidemic situation can only be based on the results of studies conducted in different countries.Objective. To assess the incidence of Haemophilus influenzae type b infection in selected countries of the world and the Russian Federation against the background of the introduction of specific vaccine prophylaxis.Conclusion. The incidence of invasive Hib infection in countries where vaccination against this infection is unavailable or has only recently been included in national vaccination programmes depends on maintaining high vaccination coverage and well-functioning surveillance systems. The persistently low incidence in all countries that have introduced Hib vaccine illustrates the success of routine vaccination programmes in providing effective protection to vaccinees and promoting collective immunity. However, the continued detection of cases of invasive forms of Haemophilus influenzae infection raises concerns that other serotypes may be displaced if mass immunisation with serotype b vaccine is carried out globally.Keywords
This publication has 56 references indexed in Scilit:
- Haemophilus influenzae serotype a meningitis in an elderly patient: A case report and literature reviewIDCases, 2024
- Global Case Fatality of Bacterial Meningitis During an 80-Year PeriodJAMA Network Open, 2024
- Trends in serotype distribution and antimicrobial susceptibility pattern of invasive Haemophilus influenzae isolates from Brazil, 2009–2021International Microbiology, 2024
- Epidemiologic study of Haemophilus influenzae causing invasive and non-invasive disease in Paraguay (1999–2017)Enfermedades Infecciosas y Microbiologia Clinica (English Ed.), 2021
- Molecular epidemiology of invasive Haemophilus influenzae disease in Portugal: an update of the post-vaccine period, 2011–2018European Journal of Clinical Microbiology & Infectious Diseases, 2020
- Two Decades of Experience With the Haemophilus influenzae Serotype b Conjugate Vaccine in the United KingdomClinical Therapeutics, 2012
- Impact of vaccination against Haemophilus influenzae type b with and without a booster dose on meningitis in four South American countriesVaccine, 2012
- The epidemiology of pneumococcal, meningococcal, and Haemophilus disease in the Middle East and North Africa (MENA) Region—Current status and needsVaccine, 2007
- Economic evaluation of Haemophilus influenzae type b vaccination in Moscow, Russian FederationVaccine, 2006
- Prospective population-based incidence of Haemophilus influenzae type b meningitis in ThailandVaccine, 2004